NCT04083820 - A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE) | Biotech Hunter

Enrollment

521

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

September 27, 2021

Study Completion Date

September 27, 2021

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

semaglutide

Patients will be treated with commercially available semaglutide in a prefilled pen injector (FlexTouch® variant) according to routine local clinical practice at the discretion of the treating physician. Other anti-hyperglycaemic treatments will be prescribed at the physician's discretion.

Trial Locations (53)

13006

Novo Nordisk Investigational Site, Marseille

14033

Novo Nordisk Investigational Site, Caen

21000

Novo Nordisk Investigational Site, Dijon

21079

Novo Nordisk Investigational Site, Dijon

21310

Novo Nordisk Investigational Site, Bèze

25000

Novo Nordisk Investigational Site, Besançon

25200

Novo Nordisk Investigational Site, Bethoncourt

26000

Novo Nordisk Investigational Site, Valence

26200

Novo Nordisk Investigational Site, Montélimar

31300

Novo Nordisk Investigational Site, Toulouse

33600

Novo Nordisk Investigational Site, Pessac

34295

Novo Nordisk Investigational Site, Montpellier

35340

Novo Nordisk Investigational Site, La Bouëxière

35500

Novo Nordisk Investigational Site, Vitré

37000

Novo Nordisk Investigational Site, Tours

37540

Novo Nordisk Investigational Site, Angers

38302

Novo Nordisk Investigational Site, Bourgoin

38500

Novo Nordisk Investigational Site, Vienne

39100

Novo Nordisk Investigational Site, Dole

43000

Novo Nordisk Investigational Site, Le Puy-en-Velay

58000

Novo Nordisk Investigational Site, Nevers

59110

Novo Nordisk Investigational Site, La Madeleine

59130

Novo Nordisk Investigational Site, Lambersart

59462

Novo Nordisk Investigational Site, Lomme

60560

Novo Nordisk Investigational Site, Orry-la-Ville

60640

Novo Nordisk Investigational Site, Guiscard

67000

Novo Nordisk Investigational Site, Strasbourg

68000

Novo Nordisk Investigational Site, Colmar

68024

Novo Nordisk Investigational Site, Colmar

69007

Novo Nordisk Investigational Site, Lyon

69110

Novo Nordisk Investigational Site, Ste Foy Lès Lyon

69200

Novo Nordisk Investigational Site, Vénissieux

69495

Novo Nordisk Investigational Site, Pierre-Bénite

71100

Novo Nordisk Investigational Site, Chalon-sur-Saône

73190

Novo Nordisk Investigational Site, Challes-les-Eaux

74600

Novo Nordisk Investigational Site, Annecy

75010

Novo Nordisk Investigational Site, Paris

75014

Novo Nordisk Investigational Site, Paris

75877

Novo Nordisk Investigational Site, Paris

76560

Novo Nordisk Investigational Site, Doudeville

76720

Novo Nordisk Investigational Site, Auffay

77500

Novo Nordisk Investigational Site, Chelles

78990

Novo Nordisk Investigational Site, Élancourt

83140

Novo Nordisk Investigational Site, Six-Fours-les-Plages

84902

Novo Nordisk Investigational Site, Avignon

91330

Novo Nordisk Investigational Site, Yerres

92110

Novo Nordisk Investigational Site, Clichy

93160

Novo Nordisk Investigational Site, Noisy-le-Grand

94360

Novo Nordisk Investigational Site, Bry-sur-Marne

94700

Novo Nordisk Investigational Site, Maison-Alfort

08000

Novo Nordisk Investigational Site, Charleville-Mézières

06202

Novo Nordisk Investigational Site, Nice

03207

Novo Nordisk Investigational Site, Vichy